GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zahravi Pharmacutical Co (XTEH:DZAH1) » Definitions » Debt-to-Asset

Zahravi Pharmacutical Co (XTEH:DZAH1) Debt-to-Asset : 0.00 (As of . 20)


View and export this data going back to 1990. Start your Free Trial

What is Zahravi Pharmacutical Co Debt-to-Asset?

Zahravi Pharmacutical Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was IRR0.00 Mil. Zahravi Pharmacutical Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was IRR0.00 Mil. Zahravi Pharmacutical Co's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in . 20 was IRR0.00 Mil.

Zahravi Pharmacutical Co Debt-to-Asset Historical Data

The historical data trend for Zahravi Pharmacutical Co's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zahravi Pharmacutical Co Debt-to-Asset Chart

Zahravi Pharmacutical Co Annual Data
Trend
Debt-to-Asset

Zahravi Pharmacutical Co Semi-Annual Data
Debt-to-Asset

Competitive Comparison of Zahravi Pharmacutical Co's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Zahravi Pharmacutical Co's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zahravi Pharmacutical Co's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zahravi Pharmacutical Co's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Zahravi Pharmacutical Co's Debt-to-Asset falls into.


Zahravi Pharmacutical Co Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Zahravi Pharmacutical Co's Debt-to-Asset for the fiscal year that ended in . 20 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=( + ) /
=N/A

Zahravi Pharmacutical Co's Debt-to-Asset for the quarter that ended in . 20 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=( + ) /
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zahravi Pharmacutical Co  (XTEH:DZAH1) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Zahravi Pharmacutical Co Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Zahravi Pharmacutical Co's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Zahravi Pharmacutical Co (XTEH:DZAH1) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zahravi Pharmacutical Co (XTEH:DZAH1) » Definitions » Debt-to-Asset
Comparable Companies
Traded in Other Exchanges
N/A
Address
18th km of Karaj Special Road, Darupakhsh Street, Darupakhsh Factories, Entrance No. 2, No. 23, Tehran, IRN
Website
http://www.zahravi.com
Zahravi Pharmacutical Co is engaged in the pharmaceutical sector. It produces various tablets, capsules, injections, and soft gel capsules. Some of its products are Cograft, Iminoral, Clexaparin, Roaccutane, and others.

Zahravi Pharmacutical Co (XTEH:DZAH1) Headlines

No Headlines